Assessing the Role of 3D Contrast-Enhanced CT Radiomics in Anticipating Neoadjuvant Chemotherapy Outcomes for Esophagogastric Junction Adenocarcinoma: Findings from a Dual-Center Investigation - Report - MDSpire
Advertisement
Assessing the Role of 3D Contrast-Enhanced CT Radiomics in Anticipating Neoadjuvant Chemotherapy Outcomes for Esophagogastric Junction Adenocarcinoma: Findings from a Dual-Center Investigation
Clinical Report: 3D Contrast-Enhanced CT Radiomics in AEG Neoadjuvant Chemotherapy
Overview
This study evaluates the predictive value of 3D contrast-enhanced CT radiomics for neoadjuvant chemotherapy outcomes in patients with adenocarcinoma of the esophagogastric junction (AEG). Findings indicate that radiomics features can assist in anticipating treatment responses, potentially guiding individualized therapeutic strategies.
Background
Adenocarcinoma of the esophagogastric junction (AEG) presents significant treatment challenges due to its high morbidity and mortality rates. Neoadjuvant chemotherapy (NAC) is increasingly utilized to improve surgical outcomes, yet not all patients respond favorably, highlighting the need for predictive models. This study aims to enhance the understanding of NAC responses through advanced imaging techniques.
Data Highlights
{'format': 'Ensure the table is properly formatted in the final document.'}
Key Findings
3D contrast-enhanced CT radiomics features can predict NAC response in AEG patients.
Patients with poor chemotherapy response exhibited significant tumor heterogeneity.
The study included a total of 239 patients across two centers, enhancing the robustness of the findings.
Integration of radiomics into clinical practice may improve individualized treatment strategies for AEG.
Neoadjuvant chemotherapy combined with surgical resection is becoming the standard treatment for locally advanced AEG.
Clinical Implications
The findings suggest that incorporating radiomics into clinical assessments may enhance the ability to predict patient responses to NAC, thereby optimizing treatment plans. This approach could reduce unnecessary chemotherapy exposure for patients unlikely to benefit from it.
Conclusion
The study underscores the potential of 3D contrast-enhanced CT radiomics as a valuable tool in predicting neoadjuvant chemotherapy outcomes for AEG, paving the way for more personalized treatment strategies.
